These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 18367829

  • 21. Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia.
    Kim M, Lee S, Jung CK, Lim J, Cho SG, Kim DW, Kim Y, Han K, Min WS, Kim CC.
    Int J Lab Hematol; 2008 Dec; 30(6):508-12. PubMed ID: 18983302
    [Abstract] [Full Text] [Related]

  • 22. Reciprocal relationship between a Ph-negative clone with trisomy 8 associated with severe myelodysplasia and a Ph-positive clone following imatinib treatment in a patient with accelerated-phase chronic myelogenous leukemia (CML).
    Patchenko P, Klepfish A, Trakhtenbrot L, Rothman R, Rachmilewitz EA.
    Am J Hematol; 2004 Dec; 77(4):420. PubMed ID: 15558793
    [No Abstract] [Full Text] [Related]

  • 23. Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia.
    Lugli A, Ebnoether M, Cogliatti SB, Gratwohl A, Passweg J, Hess U, Korte W, Hawle H, Tinguely M, Borisch B, Mach-Pascual S, Von Juergensonn S, Tichelli A, Dirnhofer S.
    Hum Pathol; 2005 Jan; 36(1):91-100. PubMed ID: 15712187
    [Abstract] [Full Text] [Related]

  • 24. Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment.
    Chung HJ, Chi HS, Cho YU, Park CJ, Seo EJ, Kim KH, Lee JH.
    Ann Clin Lab Sci; 2008 Jan; 38(3):283-6. PubMed ID: 18715859
    [Abstract] [Full Text] [Related]

  • 25. [Circumventing resistance to imatinib therapy in chronic myeloid leukemia].
    Minami Y, Naoe T.
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):544-7. PubMed ID: 19381024
    [Abstract] [Full Text] [Related]

  • 26. Adverse events after imatinib mesylate therapy.
    Burton C, Azzi A, Kerridge I.
    N Engl J Med; 2002 Feb 28; 346(9):712-3. PubMed ID: 11873781
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Imatinib mesylate plus G-CSF therapy for chronic myelogenous leukemia in the blastic crisis].
    Morita R, Hashino S, Sogabe S, Dazai M, Onozawa M, Izumiyama K, Kondo T, Ota S, Kobayashi S, Imamura M, Asaka M.
    Rinsho Ketsueki; 2004 Oct 28; 45(10):1105-10. PubMed ID: 15553045
    [Abstract] [Full Text] [Related]

  • 34. An inv(16) in Ph-negative cells of a chronic myelogenous leukemia patient after imatinib treatment.
    Rowe LR, Brothman AR, Nibley WE, Gaffney MR, Chen Z.
    Cancer Genet Cytogenet; 2007 Apr 01; 174(1):54-6. PubMed ID: 17350467
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The metabolic consequences of imatinib mesylate: Changes on glucose, lypidic and bone metabolism.
    Breccia M, Alimena G.
    Leuk Res; 2009 Jul 01; 33(7):871-5. PubMed ID: 19307018
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases.
    Brazzelli V, Prestinari F, Roveda E, Barbagallo T, Bellani E, Vassallo C, Orlandi E, Passamonti F, Borroni G.
    J Am Acad Dermatol; 2005 Nov 01; 53(5 Suppl 1):S240-3. PubMed ID: 16227099
    [Abstract] [Full Text] [Related]

  • 40. Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylate.
    LeMarbre G, Schinstock C, Hoyer R, Krook J, Tefferi A.
    Leuk Res; 2007 Mar 01; 31(3):414-5. PubMed ID: 17010430
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.